Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism ALK5 inhibitors(Transforming growth factor beta receptor 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Origo Biopharma SLStartup |
Active Organization Origo Biopharma SLStartup |
Inactive Organization AgomAb Therapeutics NVStartup |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |